Replimune (REPL) Interest & Investment Income (2018 - 2026)

Replimune (REPL) reported Interest & Investment Income of $2.4 million for Q1 2026, down 59.69% on a YoY basis from $5.9 million in Q1 2025, and down 16.76% sequentially from $2.8 million in Q4 2025.

Replimune (REPL) Interest & Investment Income (2018 - 2026) Analysis & Trends

Replimune (REPL) has 9 years of Interest & Investment Income data on file, last reported at $2.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest & Investment Income fell 59.69% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $13.6 million (down 35.48% YoY), and the FY2026 full-year result was $13.6 million, down 35.49% from the prior year.
  • Interest & Investment Income fell to $2.4 million in Q1 2026, from $2.8 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $6.2 million in Q2 2023 to a low of $131000.0 in Q1 2022.
  • A 5-year average of $4.0 million and a median of $4.7 million in 2025 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income jumped 4385.5% in 2023 and slumped 59.69% in 2026, its largest moves.
  • Tracing REPL's Interest & Investment Income over 5 years: stood at $2.7 million in 2022, then surged by 112.56% to $5.7 million in 2023, then dropped by 9.66% to $5.1 million in 2024, then tumbled by 44.6% to $2.8 million in 2025, then declined by 16.76% to $2.4 million in 2026.
  • Business Quant data shows REPL's Interest & Investment Income at $2.4 million in Q1 2026, $2.8 million in Q4 2025, and $3.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Replimune 808.32 Mn 808.32 Mn - 2.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.37 Mn
Dec 31, 2025 2.85 Mn
Sep 30, 2025 3.70 Mn
Jun 30, 2025 4.71 Mn
Mar 31, 2025 5.88 Mn
Dec 31, 2024 5.14 Mn
Sep 30, 2024 5.39 Mn
Jun 30, 2024 4.71 Mn
Mar 31, 2024 5.43 Mn
Dec 31, 2023 5.69 Mn
Sep 30, 2023 6.05 Mn
Jun 30, 2023 6.19 Mn
Mar 31, 2023 5.88 Mn
Dec 31, 2022 2.68 Mn
Sep 30, 2022 1.11 Mn
Jun 30, 2022 343,000.00
Mar 31, 2022 131,000.00
Dec 31, 2021 87,000.00
Sep 30, 2021 80,000.00
Jun 30, 2021 92,000.00